This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer.

Conditions: Neoplasms; Breast Neoplasms
Interventions: Drug: Xentuzumab; Drug: Abemaciclib; Drug: Letrozole; Drug: Anastrozole; Drug: Fulvestrant; Drug: Abemaciclib
Sponsors: Boehringer Ingelheim
Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.